Literature DB >> 18268216

Racial differences in the prevalence of age-related macular degeneration: the Salisbury Eye Evaluation (SEE) Project.

Susan B Bressler1, Beatriz Muñoz, Sharon D Solomon, Sheila K West.   

Abstract

OBJECTIVE: To determine differences in the prevalence of age-related macular degeneration (AMD) and its fundus manifestations in a population-based sample of older black and white Americans.
DESIGN: Cross-sectional population-based study of 2520 participants of whom 1854 are white and 666 are black. Mean age was 73.5 years. Stereoscopic color fundus photographs were graded for presence, severity, and location of drusen, retinal pigment epithelium abnormalities, and choroidal neovascularization or disciform scarring.
RESULTS: Drusen at least 64 microm in size were identified in 56% of black and white individuals within 3000 microm of the foveal center, but drusen larger than 125 microm were more common among white participants (16% white vs 11% black individuals). Drusen at least 250 microm in size, confluent drusen, or a larger area (> 10%) occupied by drusen were each more common among white participants. White individuals were 3 times more likely to have focal hyperpigmentation than black individuals. Racial differences were most pronounced for features within the central 1500-microm macular zone. Neovascular AMD was present in 1.7% of white participants and 1.1% of black participants (age-adjusted, P = .38), whereas geographic atrophy was more common in white than black individuals (1.8% vs 0.3%; age-adjusted, P = .02).
CONCLUSIONS: White persons are generally more likely than black persons to have medium or large drusen, focal pigment abnormalities, and advanced AMD. Racial differences were prominent for nonneovascular AMD features only when present in the central zone. These data suggest that black individuals may have a mechanism for protection in the central zone against these critical fundus features, which themselves convey high risk of progression to advanced AMD.

Entities:  

Mesh:

Year:  2008        PMID: 18268216     DOI: 10.1001/archophthalmol.2007.53

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  33 in total

Review 1.  Age-related macular degeneration: genetic and environmental factors of disease.

Authors:  Yuhong Chen; Matthew Bedell; Kang Zhang
Journal:  Mol Interv       Date:  2010-10

Review 2.  The molecular genetic basis of age-related macular degeneration: an overview.

Authors:  Saritha Katta; Inderjeet Kaur; Subhabrata Chakrabarti
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

3.  Eye Care Among US Adults at High Risk for Vision Loss in the United States in 2002 and 2017.

Authors:  Sharon H Saydah; Robert B Gerzoff; Jinan B Saaddine; Xinzhi Zhang; Mary Frances Cotch
Journal:  JAMA Ophthalmol       Date:  2020-05-01       Impact factor: 7.389

4.  Cumulative association between age-related macular degeneration and less studied genetic variants in PLEKHA1/ARMS2/HTRA1: a meta and gene-cluster analysis.

Authors:  Weihong Yu; Shuqian Dong; Chuntao Zhao; Haina Wang; Fei Dai; Jingyun Yang
Journal:  Mol Biol Rep       Date:  2013-09-07       Impact factor: 2.316

Review 5.  Risk factors and biomarkers of age-related macular degeneration.

Authors:  Nathan G Lambert; Hanan ElShelmani; Malkit K Singh; Fiona C Mansergh; Michael A Wride; Maximilian Padilla; David Keegan; Ruth E Hogg; Balamurali K Ambati
Journal:  Prog Retin Eye Res       Date:  2016-05-06       Impact factor: 21.198

6.  Iris color and associated pathological ocular complications: a review of epidemiologic studies.

Authors:  Hong-Peng Sun; Yi Lin; Chen-Wei Pan
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

7.  Prevalence of age-related macular degeneration in old persons: Age, Gene/environment Susceptibility Reykjavik Study.

Authors:  Fridbert Jonasson; Arsaell Arnarsson; Gudny Eiríksdottir; Tamara B Harris; Lenore J Launer; Stacy M Meuer; Barbara E Klein; Ronald Klein; Vilmundur Gudnason; Mary Frances Cotch
Journal:  Ophthalmology       Date:  2010-12-03       Impact factor: 12.079

8.  [What can anti-VEGF therapy achieve in clinical routine? : Effectiveness of anti-VEGF therapy in patients with macular diseases in clinical routine on 1492 eyes in Austria].

Authors:  K Wiesinger; P Reinelt; A Ennemoser; M Edelmayr; U Schönherr
Journal:  Ophthalmologe       Date:  2017-07       Impact factor: 1.059

9.  Incidence of Age-Related Macular Degeneration in a Multi-Ethnic United States Population: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Diana E Fisher; Barbara E K Klein; Tien Y Wong; Jerome I Rotter; Xiaohui Li; Sandi Shrager; Gregory L Burke; Ronald Klein; Mary Frances Cotch
Journal:  Ophthalmology       Date:  2016-02-16       Impact factor: 12.079

10.  Identification of copy number variants defining genomic differences among major human groups.

Authors:  Lluís Armengol; Sergi Villatoro; Juan R González; Lorena Pantano; Manel García-Aragonés; Raquel Rabionet; Mario Cáceres; Xavier Estivill
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.